Search Results
Jul 28, 2026, 09:29 ET Fortune gibt die Fortune-Global-500-Liste für 2026 bekannt
Heimat von fast einem Viertel der Fortune-Global-500-Unternehmen. Paris schaffte es zum ersten Mal seit 2021 wieder unter die Top 5. Die tschechische EP Group ist der erste Vertreter des Landes in den Fortune Global 500, und es gibt 14 Länder und Gebiete mit nur einem Unternehmen auf der Liste, darunter
More news about: Fortune Media (USA) Corporation
Jul 28, 2026, 06:36 ET Fortune anuncia la lista Fortune Global 500 2026
de casi una cuarta parte de las empresas de la lista Fortune Global 500. París volvió a situarse entre los cinco primeros por primera vez desde 2021. EP Group de la República Checa se convierte en el primer representante del país en la lista Fortune Global 500, y hay 14 países y territorios con una sola
More news about: Fortune Media (USA) Corporation
Jul 28, 2026, 06:01 ET Fortune Announces 2026 Fortune Global 500 List
home base to almost one-quarter of the Fortune Global 500 companies. Paris jumped back into the top five for the first time since 2021. Czech Republic's EP Group marks the country's first-ever representative on the Fortune Global 500, and there are 14 countries and territories with only one company on the
More news about: Fortune Media (USA) Corporation
Jul 28, 2026, 06:01 ET Fortune Announces 2026 Fortune Global 500 List
home base to almost one-quarter of the Fortune Global 500 companies. Paris jumped back into the top five for the first time since 2021. Czech Republic's EP Group marks the country's first-ever representative on the Fortune Global 500, and there are 14 countries and territories with only one company on the
More news about: Fortune Media (USA) Corporation
Jul 27, 2026, 23:00 ET New report identifies opportunities to help more patients in Asia Pacific benefit from advances in AFib care
ReportPFA in APAC, from Promise to Practice was commissioned by Boston Scientific and developed to better understand electrophysiologists (EP) perspectives on AFib care and the evolving role of PFA across APAC.The report is based on a double-blinded online survey of practicing EPs which
More news about: Boston Scientific
Jul 23, 2026, 09:05 ET Connamara Technologies Expands EP3® to Support Bilateral Matching and New Market Models
market participants while expanding the types of markets EP3 can support."Bilateral matching represents another step in the continued evolution of EP3's extensible, modular exchange platform. By supporting additional matching models, EP3 continues to expand the range of market structures it
More news about: Connamara Technologies
Jul 20, 2026, 07:00 ET BioLineRx and Hemispherian AS to Present Data Demonstrating Strong Synergy of GLIX1 with PARP Inhibitors in HR-Proficient Ovarian Cancers at ESMO 2026
a TET2 Activator Targeting the DNA Damage Response, Synergizes with PARP Inhibitors in Ovarian Cancer Cell LinesPresentation #: 1435ePPresentation type: e-PosterLocation: e-Poster Area, Hall 25About GLIX1GLIX1 is a first-in-class, orally
More news about: BioLineRx; Hemispherian AS
Jul 18, 2026, 03:49 ET Dimerix收購一款已具備2期臨床啟動條件的急性腎損傷候選藥物，擴充研發管線
佈中期臨床數據。[3]專利保護根據收購協議，DMX-652的物質組合物專利家族(PCT/EP2021/064897)將轉讓給Dimerix，預計有效期至2041年，同時還包括進一步背景專利及自由實施所需專利申請（PCT/GB2016/050851、PCT/GB2019/050608）的獨家許可。除專利保護外，若成功取得孤兒藥資格認定，DMX-652獲批上市後至少享有5年市場獨佔保護；美國市場獨佔期最長可延長至7年，歐洲地區最長可達10年。協議條款根據協議條款，Dimerix將擁有DMX-652的獨家所有權並控制其開發。相應地，Dimerix需在協議簽署後30日內向英國Mission
More news about: Dimerix Limited
Jul 17, 2026, 07:00 ET DIMERIX EXPANDS PIPELINE WITH ACQUISITION OF PHASE 2 READY ASSET FOR ACUTE KIDNEY INJURY
anticipated during 2027.[3]Patent ProtectionUnder the acquisition, the composition of matter patent family for DMX-652 (PCT/EP2021/064897) will be assigned to Dimerix, with anticipated expiry in 2041, as well as the exclusive license to further background patents and patent applications
More news about: Dimerix Limited
Jul 16, 2026, 16:17 ET Monk Launches Cash Application 2.0, Automating 80% of Payment Matching with a Fully Auditable AI Engine
platform. Monk raised $25M to help businesses get paid fast and is based in New York. Learn more at monk.com.MediaAR is Broken Ep. 1 | Automating Cash Application, featuring Nurah Kutty (YouTube:
More news about: Monk
Jul 16, 2026, 12:26 ET Jay Walker Hit Podcast Expands to 4 Days a Week, Sets Premiere Date & Names Sean Atkins EP
anywhere else. Our new multi-million dollar studio in Nashville gives us the elite infrastructure to match our vision, and bringing Sean Atkins on board as EP gives us the creative leverage we need to scale this beast. With guests like Kamala Harris, Kevin Hart, and Ben Crump coming to the table, we are taking
More news about: A1 LLC
Jul 16, 2026, 03:00 ET POLYTECH Announces the approval of updated process for Microthane®*
product through a unique and proprietary manufacturing process.The updated manufacturing process is the subject of European patent application EP26184379.1 of 10 June 2026, reinforcing POLYTECH's ongoing commitment to innovation and intellectual property."Innovation at POLYTECH is
More news about: POLYTECH Health & Aesthetics GmbH
Jul 15, 2026, 00:30 ET Making Strides in Cardiac Healthcare at Zydus Hospitals, Gujarat
structurally sound.Cardiac Electrophysiology (EP) is a highly specialised sub-discipline of cardiology dedicated to diagnosing and treating heart rhythm disorders. Patients typically present with palpitations,
More news about: Zydus Hospitals and Healthcare Research Private Limited
Jul 13, 2026, 08:48 ET Montréal Alt-Rock Singer-Songwriter Silka Weil Releases Sophomore EP 'Midnight Blue'
MONTREAL, July 13, 2026 /PRNewswire/ -- Montréal's Silka Weil releases her long-anticipated sophomore EP, 'Midnight Blue,' out now on all platforms. The Musi-Flo Artist of the Year follows her celebrated 2023 debut with a record that pushes further into both
More news about: Silka Weil
Jul 13, 2026, 04:56 ET Leads Biolabs Announces Multiple Studies Selected for ESMO 2026, Highlighting the Growing Global Competitiveness of Its Core Pipeline
oral presentation format, while four will be presented as posters, covering multiple tumor types such as extrapulmonary neuroendocrine carcinoma (EP‑NEC), biliary tract cancer (BTC), and relapsed/refractory multiple myeloma (RRMM). In addition, the Company has been granted a Late‑Breaking Abstract (LBA)
More news about: Leads Biolabs
Jul 12, 2026, 23:58 ET STL gewinnt Patentstreit in Europa eindeutig und bekräftigt sein Engagement für den Schutz seiner Innovationen und seines geistigen Eigentums
einer mündlichen Verhandlung am 24. Juni 2026 eine endgültige, verbindliche und nicht anfechtbare Entscheidung erlassen, mit der das europäische Patent EP 3796060 von Fujikura in seiner Gesamtheit für nichtig erklärt wurde. Das Urteil entscheidet den britischen Patentstreit zwischen den Parteien zugunsten
More news about: Sterlite Technologies Ltd. (STL)
Jul 10, 2026, 17:00 ET Summary Notice of Pendency and Proposed Settlement of Stockholder Derivative Action
)Case No. 2:21-cv-12025-EP-SDASUMMARY NOTICE OF PENDENCY AND PROPOSED SETTLEMENT OF STOCKHOLDER
More news about: Cognizant Technology Solutions Corporation
Jul 10, 2026, 13:49 ET STL gana decisivamente una disputa de patentes en Europa
(EPO), en una audiencia celebrada el 24 de junio de 2026, emitió una resolución final, vinculante e inapelable que revoca íntegramente la patente europea EP 3796060 de Fujikura. Esta resolución resuelve la disputa de patentes en el Reino Unido a favor de STL.
More news about: Sterlite Technologies Ltd. (STL)
Jul 10, 2026, 13:46 ET STL obtient gain de cause dans un litige de brevet en Europe ; l'entreprise réaffirme sa détermination à défendre ses innovations et sa propriété intellectuelle
(OEB) a rendu une décision définitive, contraignante et non susceptible d'appel révoquant dans son intégralité le brevet européen EP 3796060 de Fujikura. Cette décision tranche en faveur de STL le litige relatif à un brevet du Royaume-Uni opposant les parties.
More news about: Sterlite Technologies Ltd. (STL)
Jul 10, 2026, 10:17 ET STL decisively wins Patent Dispute in Europe; reaffirms commitment to defending its Innovation and Intellectual Property
(EPO) Technical Board of Appeal at a hearing on 24 June, 2026, has issued a final, binding and non-appealable ruling revoking Fujikura's European Patent EP 3796060 in its entirety. The ruling resolves the UK patent dispute between the parties in STL's favour.
More news about: Sterlite Technologies Ltd. (STL)
Jul 10, 2026, 10:10 ET STL decisively wins Patent Dispute in Europe; reaffirms commitment to defending its Innovation and Intellectual Property
(EPO) Technical Board of Appeal at a hearing on 24 June, 2026, has issued a final, binding and non-appealable ruling revoking Fujikura's European Patent EP 3796060 in its entirety. The ruling resolves the UK patent dispute between the parties in STL's favour.
More news about: Sterlite Technologies Ltd. (STL)
Jul 10, 2026, 04:53 ET Priority Review Granted to PD-L1/4-1BB Bispecific Antibody Opamtistomig, Accelerating Commercialization and Addressing Unmet Need in EP-NEC
possible."About EP-NECEP-NEC is a highly aggressive immunologically cold tumor for which no therapy has been approved by any regulatory authority worldwide. Platinum-based chemotherapy remains the standard first-line treatment for patients with advanced EP-NEC, with a median overall
More news about: Nanjing Leads Biolabs Co., Ltd.
Jul 08, 2026, 09:04 ET Eligible Original Medicare patients can now access Nerva's gut-brain therapy program at no out-of-pocket cost
active control) met the trial's primary endpoint (p=0.002), with improvements broadly maintained at six months. Anderson EJ, Peters SL, Gibson PR, Halmos EP. Comparison of digitally delivered gut-directed hypnotherapy program with an active control for irritable bowel syndrome. Am J Gastroenterol. 2025;120(2):440-448.
More news about: Mindset Health
Jul 06, 2026, 08:55 ET As AI Models Become Commodities, a Bio-Native AI Company Just Moved to Patent the Data Layer Beneath the Models
Key TakeawaysMindWalk Holdings Corp. (NASDAQ: HYFT) filed European patent application No. EP26187897.9, directed to high-dimensional data structures for biological subsequences and property inference, intended to protect the enriched biological representation
More news about: USA News Group
Jul 01, 2026, 09:50 ET Enverus ranks top U.S. private E&P operators
content to download multimedia:https://www.prnewswire.com/news-releases/enverus-ranks-top-us-private-ep-operators-302815400.htmlSOURCE Enverus
More news about: Enverus